IDH2 and astrocytoma (excluding glioblastoma): Another major change made in WHO CNS5 is that IDH-mutant astrocytomas that show grade 4 features are no longer termed “glioblastoma”, as this is now a diagnosis reserved for IDH-wildtype tumours (see below).